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Abstract 
The HICAT project is a Heavy Ion accelerator for 
light ion Cancer Treatment to be built for the clinics in 
Heidelberg, Germany. It consists of a 7 MeV/u linac, a 
compact synchrotron and three treatment places, one of 
them located after a 360 degree gantry beam-line. The 
facility will implement the intensity controlled raster-
scanning technique that was developed and successfully 
demonstrated at GSI. In order to produce the beams 
with the characteristics requested by the treatment 
sequencer, the accelerator must operate on a pulse-to-
pulse basis with different settings. This concept 
imposes strict and challenging demands on the 
operation of the accelerators and hence the control 
system of the facility. The control system should be 
developed, installed and maintained by and under the 
complete responsibility of an industrial system 
provider, using a state-of-the-art system and wide-
spread industrial components wherever possible. This 
presentation covers the status of the project and the 
requirements on the control system. 
1  HICAT MACHINE LAYOUT 
The HICAT accelerator facility was designed to 
meet the medical requirements used for the successful 
GSI cancer treatment program. HICAT consists of two 
ECR ion sources with independent spectrometer lines 
to produce both low LET ions (p, He) and high LET 
ions (C, O) to cover the medical requirements and 
allow for fast switching. The beams will be accelerated 
by a compact-designed 7 MeV/u linac (RFQ and IH-
DTL) and a 6.5 Tm synchrotron for beam energies of 
up to 430 MeV/u. In order to meet the intensity 
requirements, multi-turn injection will be used for beam 
accumulation. For extraction, the rf knock-out method 
in combination with a variable extraction time will be 
implemented. The beams can be delivered to three 
medical treatment areas, located after two fixed 
horizontal beam lines and one 360° rotating beam 
transport system (isocentric gantry), as well as one 
quality assurance/experimental place. 
No passive elements are foreseen to match the dose 
distribution to the individual tumor geometry. Instead, 
all beam lines will be equipped with horizontal and 
vertical scanning magnets and beam diagnostic devices 
for the intensity controlled-raster scanning technique 
that was developed and successfully demonstrated 
within the GSI experimental cancer treatment program 
with over 100 patients to date. 
Fig. 1 shows the cross section of the first 
underground floor of the building which houses the 
accelerator sections, the patient treatment areas, local 
control rooms and various laboratories and offices. For 
a general description of the accelerator complex, 
see [1]. 
2  CONTROL SYSTEM 
For the realization of the HICAT project, a close 
cooperation with industry is necessary. GSI has done 
the machine layout and worked out crucial  technical 
specifications. The development and implementation of 
the control system will be performed by a commercial 
firm. 
Therefore, the HICAT control system (cs) should be 
delivered under a supply contract established with an 
industrial system provider. The full development and 
configuration of the system will be the responsibility of 
the contractor, who will also perform commissioning 
and all tests on the site. GSI will advise and supervise 
the commercial contractor during the project. 
The cs should be based on an industrial control 
system (e.g. commercially available SCADA system) 
that fulfills the specific requirements for controlling the 
facility. At a life cycle of 20 or more years, quite 
reasonable for such a system, the cs must be laid out for 
long service. Consequently, it is proposed to use wide-
spread industrial standards and commercial solutions 
wherever possible. 
The cs must meet the following general 
requirements: 
• high reliability 
• easy and efficient operation by a small crew 
• development and maintenance by industry 
Since a reliable control system is an indispensable 
element to supply beams for medical practice the 
system has to respect stringent requirements in terms of 
reliability, safety, maintainability and legal aspects such 
as the ones required by regulatory authorities. It must 
meet the following general requirements: 
The HICAT cs runs the accelerator in a hospital 
environment. It must be easy to operate because daily 
  
operation of the accelerator is carried out by operators 
who are not necessarily accelerator specialists. The 
control system’s functionality is determined by these 
facts, together with the controls demands of the 
accelerator facility in itself. 
In particular, the following major tasks have to be 
covered by the accelerator cs: 
• full control of the accelerator systems to deliver 
and assure a beam with characteristics requested 
by the patients’ treatment plan on a pulse to pulse 
basis 
• full control of the patient irradiation treatment with 
prescribed treatment plan and measure compliance 
of treatment 
• patients’ protection against wrong treatment 
• control of all secondary and infrastructure systems 
• minimal personal employment for controlling 
The HICAT cs should be completely integrated, i.e. a 
single set of standards will be applied to all aspects of 
the facility. Although it is not the usual practice to 
include conventional facility controls in the accelerator 
cs, experience shows that signals from these systems 
are needed in the control room. 
All systems – accelerators and conventional facilities 
– will be operated and monitored from a single control 
room. In addition there will be treatment control rooms 
for each treatment place from where the actual 
treatment is controlled and monitored. 
3  TECHNICAL CONTROL 
REQUIREMENTS 
Major aspects of the control system design are 
influenced by the experiences of the GSI cancer 
treatment program [2]; the requirements of this facility, 
however, exceeds those of the pilot project. 
Logically, the HICAT cs will consist of two major 
integrated parts: 
• the accelerator control system – controls the 
accelerator and all auxiliary systems 
• control system for the medical treatment (one 
independent system for each treatment place) – 
controls the treatment sequencer and all treatment 
instrumentation 
3.1 Process Data 
The main characteristics of the HICAT facility are 
the application of the raster-scan method with active 
intensity-, energy- and beam size-variation in 
combination with the usage of an isocentric gantry to 
match the dose distribution to the individual tumor 
geometry. During the patient irradiation process 
(treatment mode) the treatment sequencer requests 
beams with certain characteristics on a pulse-to-pulse 
basis. The beam characteristics are fixed and pre-
defined in a library of settings, e.g. 255 possible beam 
energy steps (Table 1). The task of the accelerator 
control system is to deliver these beams as requested. 
Table 1: Process parameters 
Steps Parameter 
4 ion species (p, He, C, O) 
255 beam energy (50–430 MeV/u) 
4 focus diameter (4–10 mm) 
15 intensity level (variation 1 to 10
-3
) 
~36 gantry angle (angle interpolation) 
4 treatment area (beam lines) 
 
In order to achieve high operational reliability the cs 
must meet the following requirements: 
• use only proven and validated settings, 
• protect settings from loss and accidental 
modification, 
• inhibit operator's access/interference during 
irradiation, 
• avoid networking for settings, provide all beams in 
stand-by on a pulse-to-pulse basis, 
These requirements lead to a high number of settings 
(up to 100,000 per device) to hold at the device 
controller. Fortunately, the settings of the devices do 
not depend on all parameters in Table 1 at the same 
time. Because of the high number of data sets needed, 
manual tuning of the machine is prohibitive. To derive 
data automatically, a “theoretical model” of the 
accelerator will be used, allowing calculation of all 
device data from high-level machine parameters and 
applying once measured corrections. 
 
3.2 Timing system 
For the entire accelerator chain, including linac rf-
structures, choppers, bunchers, and all synchrotron 
devices, a strict synchronization is required. Some 
time-critical functions (i.e. triggers, acceleration ramps) 
must by synchronized within ∆t<1–5 µs at the worst. 
The cs must implement a timing controller that 
provides a system-wide synchronization for distributed 
devices with real-time performance. The system must 
be flexible enough to react on requests for beam 
extraction pauses and aborts. 
 
  
3.3 Patient safety 
Safety is a crucial issue for the cs, considering the 
special task of the facility. Due to the high number of 
devices acting on the beam, the accelerator control 
system cannot guarantee safe operation. Instead, it will 
implement a fast and fail-safe beam-abort system that 
reliably stops the beam within 200 µs. This is achieved 
by simultaneously triggering a chain of different actions 
using different devices which are all, by themselves, 
capable to prevent beam delivery to the treatment 
place. 
The sophisticated on-line beam diagnostics of the 
treatment sequencer verifies the correctness of the 
beam parameters (position, focus, intensity) with 
respect to the treatment plan. In case of intolerable 
deviations to the treatment plan or failure of critical 
systems, the treatment control system triggers beam-
abort channels to stop the irradiation treatment. 
 
3.4 Scanner system 
For the real-time treatment sequencer it is foreseen to 
use the existing state-of-the-art GSI-system [3] and 
adapt it to the new environment. The functions will be 
extended to feature gated beam extraction and end of 
extraction ahead of schedule. 
4  STATUS AND OUTLOOK 
Currently all essential technical specifications and 
requirements for the entire facility including the control 
system are being worked out. 
Following the final approval by the board of the 
clinics by the end of 2001 an ambitious time schedule 
will be established. For the first quarter of 2002 a call 
for tender is scheduled. Contracts with industries are 
foreseen around middle of 2002. 
According to the current project plan the first beam 
is scheduled in 2005 and the first patient treatments 
should take place in 2006 after an extensive 
commissioning phase. 
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Figure 1: First underground level of the HICAT facility. 
